Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to improve outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 1×
“Opportunistic infection following respiratory viral infection has been recognized since the 1918 influenza pandemic [6].”
BackgroundZheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Schauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30274-1 · Cited by 886
Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections
Gill, J. R., Sheng, Z.-M., Ely, S. F., Guinee, D. G., Beasley, M. B., Suh, J., Deshpande, C., Mollura, D. J., Morens, D. M., Bray, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.235 · Cited by 426
Pittet, L. A., Hall-Stoodley, L., Rutkowski, M. R., & Harmsen, A. G. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0417oc · Cited by 216 · cited 1×
“Respiratory viruses also disrupt normal ciliary clearance [15], cause leukopenia”
BackgroundDiagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults.
Cunha, B. A., Pherez, F. M., & Schoch, P. (2009) · Clinical Infectious Diseases · doi:10.1086/644496 · Cited by 104
Cited by
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421
Self-citationBassetti, M., Azoulay, E., Kullberg, B.-J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 327
PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
Clancy, C. J., Buehrle, D. J., & Nguyen, M. H. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa049 · Cited by 102
Self-citationRace and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
“can cause a spectrum of disease in humans, from non-invasive diseases such as allergic bronchopulmonary aspergillosis that are associated with exacerbation of different underlying lung diseases, to life-threatening infections such as invasive pulmonary aspergillosis, including in those with COVID-19 infection [8,67,68…”
BackgroundSelf-citationTrevijano-Contador, N., Torres-Cano, A., Carballo-González, C., Puig-Asensio, M., Martín-Gómez, M. T., Jiménez-Martínez, E., Romero, D., Nuvials, F. X., Olmos-Arenas, R., Moretó-Castellsagué, M. C., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac605 · Cited by 54
“8 • OFID • Trevijano-Contador et al diseases, such as COVID-associated pulmonary aspergillosis (CAPA) [36–38], mucormycosis [39–41], and Candida infections [42, 43] (see reviews in [44, 45]).”
Background
Metadata
- Authors
- Thompson III, G. R., Cornely, O. A., Pappas, P. G., Patterson, T. F., Hoenigl, M., Jenks, J. D., Clancy, C. J., & Nguyen, M. H.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-06-19
- Volume
- 7
- Issue
- 7
- Pages
- ofaa242-ofaa242
- ISSN
- 2328-8957 (ISSN-L)
- OpenAlex
- W3036050467
- Cited by
- 85
- References
- 9
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19. https://app.cochat.ai/papers/10.1093/ofid/ofaa242
- The paper
- Thompson III, G. R., Cornely, O. A., Pappas, P. G., Patterson, T. F., Hoenigl, M., Jenks, J. D., Clancy, C. J., & Nguyen, M. H. (2020). Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofaa242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.